US2009191197A1
|
|
Cancerous disease modifying antibodies
|
US2009191119A1
|
|
Cancerous disease modifying antibodies
|
US2009191120A1
|
|
Cancerous disease modifying antibodies
|
US2010158801A1
|
|
Methods for the treatment of acute myeloid leukemia
|
US2009104115A1
|
|
Cancerous disease modifying antibodies
|
US2009068099A1
|
|
Cancerous disease modifying antibodies
|
US2009068100A1
|
|
Cancerous disease modifying antibodies
|
US2008305104A1
|
|
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
US2009047213A1
|
|
Cytotoxicity mediation of cells evidencing surface expression of CD59
|
US2009004103A1
|
|
Cytotoxicity mediation of cells evidencing surface expression of CD44
|
US2008213170A1
|
|
Cancerous Disease Modifying Antibodies
|
US2008206133A1
|
|
Cancerous Disease Modifying Antibodies
|
US2008241062A1
|
|
Cancerous disease modifying antibodies
|
US2008219919A1
|
|
Cytotoxicity mediation of cells evidencing surface expression of CD44
|
US2008044408A1
|
|
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
US2006216235A1
|
|
Cancerous disease modifying antibodies
|
US7442776B2
|
|
Cancerous disease modifying antibodies
|